[1]
Grohs, J.G. et al. 2007. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthopaedica. 78, 1 (Jan. 2007), 95–98. DOI:https://doi.org/10.1080/17453670610013484.